Skip to main content
LEAP THERAPEUTICS, INC. logo

LEAP THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · LPTX ISIN · US52187K2006 LEI · 549300T31SMMJ2DDLI13 US Manufacturing
Filings indexed 584 across all filing types
Latest filing 2022-09-07 Board/Management Inform…
Country US United States of America
Listing US LPTX

About LEAP THERAPEUTICS, INC.

https://www.leaptx.com/

Leap Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics for cancer. Its most advanced clinical candidate, DKN-01 (sirexatamab), is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, being developed for patients with esophagogastric, gynecologic, and colorectal cancers. The company's pipeline also includes FL-301, a monoclonal antibody targeting Claudin18.2 for gastric and pancreatic cancer, and FL-501, a preclinical antibody targeting the growth and differentiation factor 15 (GDF-15) protein.

Recent filings

Filing Released Lang Actions
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce significant events. The content includes the appointment of a new director to the Board of Directors and references to press releases about this appointment and a presentation at a congress. There are no financial statements or detailed financial data presented. The primary focus is on management changes and announcements of events. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document is not an Annual Report, Earnings Release, or any other financial report type. Therefore, the correct classification is MANG with high confidence.
2022-09-07 English
OWNERSHIP DOCUMENT
Director's Dealing
2022-09-03 English
OWNERSHIP DOCUMENT
Director's Dealing
2022-09-03 English
OWNERSHIP DOCUMENT
Director's Dealing
2022-09-03 English
OWNERSHIP DOCUMENT
Director's Dealing
2022-09-03 English
OWNERSHIP DOCUMENT
Director's Dealing
2022-09-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.